top of page
  • Writer's pictureHenri Spronk

LifeScience Sweden Reports on Coagulation Profile B.V.

The website lifesciencesweden.se publiced a background article titled "Innovative start-up helps doctors, scientists and industry balance coagulation risks" on the origin of Coagulation Profile B.V. and the potential application of thrombin generation for profiling the coagulation profile of an individual. The story, written by Maria Dalby, for which the summary is provided below, can be read here.


"For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thrombosis is an ongoing challenge. In the late 1980s, scientists at Maastricht University in the Netherlands developed an innovative method, the thrombin generation assay (TGA), which provides a complete overview of a physiological process crucial for maintaining normal haemostasis."






9 views0 comments

Recent Posts

See All

Comments


bottom of page